Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

NCT03031535 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dauntless Pharmaceuticals